QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells 期刊论文 Cancer Cell International, 2021, 卷号: 21, 期号: 1, 页码: 12 作者:  Zhao,Xueshan;  Jin,Xiaodong;  Zhang,Qiuning;  Liu,Ruifeng;  Luo,Hongtao 收藏  |  浏览/下载：223/0  |  提交时间：2021/12/13 LncRNA H19  MiR-130a-3p  WNK3  Non-small-cell lung cancer  Radiotherapy   Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGF beta signaling 期刊论文 ONCOGENE, 2021, 页码: 10 作者:  Kong, Ya;  Zhang, Yutian;  Wang, Hanlin;  Kan, Weijuan;  Guo, Haoran 收藏  |  浏览/下载：51/0  |  提交时间：2022/01/04 A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor 期刊论文 JOURNAL OF SEPARATION SCIENCE, 2021, 页码: 8 作者:  Zhou, Jun;  Zhan, Yan;  Zhong, Dafang;  Chen, Xiaoyan;  Zhang, Yifan 收藏  |  浏览/下载：72/0  |  提交时间：2021/11/04 chimmitecan  mass spectrometry  pharmacokinetics  simmitecan  solid tumors   Pulmonary enteric adenocarcinoma 期刊论文 TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14 作者:  Gong, Jiali;  Fan, Ying;  Lu, Hongyang 收藏  |  浏览/下载：54/0  |  提交时间：2021/11/01 PEAC  Immunohistochemistry  Mutation analysis  Diagnosis  Prognosis   Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients 期刊论文 THORACIC CANCER, 2021 作者:  Gong, Lei;  He, Ronghui;  Xu, Yanjun;  Luo, Taobo;  Jin, Kaixiu 收藏  |  浏览/下载：38/0  |  提交时间：2021/08/31 biomarker  neoantigen load  NSCLC  prognosis  whole exome sequencing   KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Xie, Mingying;  Xu, Xiaoling;  Fan, Yun 收藏  |  浏览/下载：45/0  |  提交时间：2021/06/15 KRAS-mutant  NSCLC  targeted therapy  immunotherapy  AMG510  MRTX849   Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 期刊论文 EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897 作者:  Lu, Tingting;  Cao, Jiangyan;  Zou, Fengming;  Li, Xixiang;  Wang, Aoli 收藏  |  浏览/下载：42/0  |  提交时间：2021/04/26 BCR-ABL  ABL mutants  Chronic myeloid leukemia  Kinase inhibitor  Imatinib resistance   Design, synthesis and pharmacological evaluation of bicyclic and tetracyclic pyridopyrimidinone analogues as new KRAS(G12C) inhibitors 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 213, 页码: 17 作者:  Xiao, Xuanzheng;  Lai, Mengzhen;  Song, Zilan;  Geng, Meiyu;  Ding, Jian 收藏  |  浏览/下载：47/0  |  提交时间：2021/05/24 KRAS  Covalent inhibitor  Pyridopyrimidinone  Antiproliferative effect  Scaffold hopping   Role of oncogene PIM-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress 期刊论文 MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2021, 卷号: 523 作者:  Wen, Qing-Liang;  Yi, He-Qing;  Yang, Ke;  Yin, Chang-Tian;  Yin, Wen-Juan 收藏  |  浏览/下载：25/0  |  提交时间：2021/03/15 Papillary thyroid carcinoma  PIM-1  Oxidative stress  NOX4   NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC 期刊论文 CANCER BIOLOGY & THERAPY, 2021 作者:  Zhou, Xia;  Bao, Wuan;  Zhang, Danhong;  Yang, Yang;  Du, Xianghui 收藏  |  浏览/下载：35/0  |  提交时间：2021/04/26 NCK1-AS1  NCK1  LUSC  MYC